We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$372M
AUM Growth
+$10.5M
Cap. Flow
+$3.66M
Cap. Flow %
0.99%
Top 10 Hldgs %
17.28%
Holding
264
New
49
Increased
26
Reduced
48
Closed
45

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$3.95M
2
GNRC icon
Generac Holdings
GNRC
+$3.69M
3
XYL icon
Xylem
XYL
+$3.63M
4
CHRW icon
C.H. Robinson
CHRW
+$3.57M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$3.51M

Top Sells

Rank Stock Value
1
IPXL
Impax Laboratories, Inc.
IPXL
+$3.89M
2
PPC icon
Pilgrim's Pride
PPC
+$3.75M
3
CL icon
Colgate-Palmolive
CL
+$3.58M
4
WNC icon
Wabash National
WNC
+$3.19M
5
USNA icon
Usana Health Sciences
USNA
+$3.01M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 16.03%
3 Consumer Discretionary 15.97%
4 Materials 12.67%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNBR
251
DELISTED
Sleep Number
SNBR
– –
-27,300
Closed -$960K
SUN icon
252
Sunoco
SUN
$14.3B
– –
-20,000
Closed -$510K
TRV icon
253
Travelers Companies
TRV
$77.9B
– –
-10,000
Closed -$1.39M
USNA icon
254
Usana Health Sciences
USNA
$419M
– –
-35,000
Closed -$3.01M
W icon
255
Wayfair
W
$11.9B
– –
-15,000
Closed -$1.01M
WNC icon
256
Wabash National
WNC
$501M
– –
-153,500
Closed -$3.19M
SGI
257
Somnigroup International
SGI
$14.1B
– –
-106,800
Closed -$1.21M
SRCL
258
DELISTED
Stericycle Inc
SRCL
– –
-25,000
Closed -$1.46M
CSII
259
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-50,000
Closed -$1.1M
NTRI
260
DELISTED
NutriSystem, Inc.
NTRI
– –
-25,000
Closed -$674K
IPXL
261
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-200,000
Closed -$3.89M
WLH
262
DELISTED
WILLIAM LYON HOMES
WLH
– –
-4,000
Closed -$110K
LPNT
263
DELISTED
LifePoint Health, Inc.
LPNT
– –
-50,000
Closed -$2.35M
AAN.A
264
DELISTED
The Aaron's Company Inc Class A
AAN.A
– –
-1,300
Closed -$61K
7 8 9 10
11

Similar funds

CPIM
Coalescence Partners Investment Management New York $463M AUM 8.27% 1-Year Est. Return
CWWM
Clear Wave Wealth Management Red Bank, New Jersey $463M AUM
NG
NatWest Group Edinburgh, Scotland, United Kingdom $462M AUM 47.31% 1-Year Est. Return
PC
ParaFi Capital New York $462M AUM 12.81% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
FNBTCON
First National Bank & Trust Co of Newtown Newtown, Pennsylvania $464M AUM 17.66% 1-Year Est. Return

Hussman Strategic Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Hussman Strategic Advisors held 264 positions worth $372M, up 2.9% from $361M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hussman Strategic Advisors's Q2 2018 filing shows 49 new, 26 increased, 48 reduced and 45 closed positions. Its largest new stake was Fastenal: 304,800 shares worth $3.67M. The largest sale was Impax Laboratories, Inc., an estimated $3.89M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Hussman Strategic Advisors's largest Q2 2018 buy was Fastenal: 304,800 shares worth $3.67M.
  • Hussman Strategic Advisors added most to C.H. Robinson in Q2 2018, an estimated $3.57M increase.
  • Hussman Strategic Advisors's biggest Q2 2018 reduction was Varian Medical Systems, Inc., cutting an estimated $2.99M.
  • Hussman Strategic Advisors fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $3.89M.
  • Hussman Strategic Advisors's ten largest holdings make up 17% of its $372M portfolio in Q2 2018.
  • Hussman Strategic Advisors opened 49 new positions and closed 45 in Q2 2018.
  • Hussman Strategic Advisors's portfolio value rose 2.9% quarter-over-quarter to $372M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2018, filed 31 Jul 2018.